Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-01-01 @ 1:12 PM
Study NCT ID:
NCT04984356
Status:
COMPLETED
Last Update Posted:
2025-09-30
First Post:
2021-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL
Sponsor:
Wugen, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-08
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-29
First Submit QC Date:
None
Study First Post Date:
2021-07-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-24
Last Update Post Date:
2025-09-30
Last Update Post Date Type:
ESTIMATED